Retracted: Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo

Authors

  • Sanjeev Banerjee,

    1. Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Wayne State University, Detroit, MI
    Search for more papers by this author
  • Dejuan Kong,

    1. Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Wayne State University, Detroit, MI
    Search for more papers by this author
  • Asfar S. Azmi,

    1. Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Wayne State University, Detroit, MI
    Search for more papers by this author
  • Zhiwei Wang,

    1. Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Wayne State University, Detroit, MI
    Search for more papers by this author
  • Aamir Ahmad,

    1. Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Wayne State University, Detroit, MI
    Search for more papers by this author
  • Seema Sethi,

    1. Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Wayne State University, Detroit, MI
    Search for more papers by this author
  • Fazlul H. Sarkar

    Corresponding author
    1. Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Wayne State University, Detroit, MI
    • Department of Pathology, 740 HWCRC Bldg, 4100 John R Street, Detroit, MI 48201, USA

    Search for more papers by this author
    • Tel.: +313-576-8327, Fax: 313-576-8389

Errata

This article is corrected by:

  1. Errata: Retraction Volume 139, Issue 9, 2146, Article first published online: 18 August 2016

Abstract

This article has been retracted at the request of: Editor-in-Chief and Co-author

‘Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo’ by Banerjee, S., Kong, D., Azmi, A. S., Wang, Z., Ahmad, A., Sethi, S. and Sarkar, F. H.

The above article, published online on 16 November 2010, in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor-in-Chief, Professor Peter Lichter, and Wiley Periodicals, Inc. A university investigation involving the first and corresponding author determined that several figures in this paper were mislabeled, manipulated, or duplicated and relabeled while processing/compiling the final figures assembled from the original data sources. Therefore, the authors are retracting the paper in its entirety although they maintain that these issues did not affect the major conclusions. They apologize for any inconvenience this may have caused.

Reference

Banerjee, S., Kong, D., Azmi, A. S., Wang, Z., Ahmad, A., Sethi, S. and Sarkar, F. H. (2011), Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo. Int. J. Cancer, 128: 1240–1250. doi: 10.1002/ijc.25658

Ancillary